Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 10, 2021

SELL
$4.37 - $9.46 $5.3 Million - $11.5 Million
-1,213,328 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$8.56 - $26.93 $264,461 - $832,002
-30,895 Reduced 2.48%
1,213,328 $11 Million
Q2 2020

Aug 12, 2020

BUY
$21.21 - $31.55 $17.4 Million - $25.8 Million
818,542 Added 192.29%
1,244,223 $34.2 Million
Q1 2020

May 12, 2020

BUY
$18.43 - $38.04 $7.85 Million - $16.2 Million
425,681 New
425,681 $9.37 Million

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.